@misc{indiciaeeee987d1172b,
  title = {M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors},
  author = {Takamori, S. and Haratake, N. and Bhattacharya, A. and Ozawa, H. and Shigeta, K. and Onishi, M. and Komiya, T. and Komatsuda, H. and Takenaka, T. and Yoshizumi, T. and Li, C. and Deng, J. and Hata, A. N. and Wong, K. K. and Long, M. D. and Kufe, D.},
  year = {2025},
  doi = {10.64898/2025.12.02.691049},
  url = {https://www.biorxiv.org/content/10.64898/2025.12.02.691049v1},
  note = {Source identifier: 10.64898/2025.12.02.691049}
}